Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Jan 25;19(1):e0278432. doi: 10.1371/journal.pone.0278432

Effects of relaxation interventions during pregnancy on maternal mental health, and pregnancy and newborn outcomes: A systematic review and meta-analysis

Mubarek Abera 1,*, Charlotte Hanlon 2,3, Beniam Daniel 4, Markos Tesfaye 5,6, Abdulhalik Workicho 7, Tsinuel Girma 8, Rasmus Wibaek 9, Gregers S Andersen 9, Mary Fewtrell 10, Suzanne Filteau 11, Jonathan C K Wells 10
Editor: Daniel Ahorsu12
PMCID: PMC10810490  PMID: 38271440

Abstract

Background

Stress during pregnancy is detrimental to maternal health, pregnancy and birth outcomes and various preventive relaxation interventions have been developed. This systematic review and meta-analysis aimed to evaluate their effectiveness in terms of maternal mental health, pregnancy and birth outcomes.

Method

The protocol for this review is published on PROSPERO with registration number CRD42020187443. A systematic search of major databases was conducted. Primary outcomes were maternal mental health problems (stress, anxiety, depression), and pregnancy (gestational age, labour duration, delivery mode) and birth outcomes (birth weight, Apgar score, preterm birth). Randomized controlled trials or quasi-experimental studies were eligible. Meta-analyses using a random-effects model was conducted for outcomes with sufficient data. For other outcomes a narrative review was undertaken.

Result

We reviewed 32 studies comprising 3,979 pregnant women aged 18 to 40 years. Relaxation interventions included yoga, music, Benson relaxation, progressive muscle relaxation (PMR), deep breathing relaxation (BR), guided imagery, mindfulness and hypnosis. Intervention duration ranged from brief experiment (~10 minutes) to 6 months of daily relaxation. Meta-analyses showed relaxation therapy reduced maternal stress (-4.1 points; 95% Confidence Interval (CI): -7.4, -0.9; 9 trials; 1113 participants), anxiety (-5.04 points; 95% CI: -8.2, -1.9; 10 trials; 1965 participants) and depressive symptoms (-2.3 points; 95% CI: -3.4, -1.3; 7 trials; 733 participants). Relaxation has also increased offspring birth weight (80 g, 95% CI: 1, 157; 8 trials; 1239 participants), explained by PMR (165g, 95% CI: 100, 231; 4 trials; 587 participants) in sub-group analysis. In five trials evaluating maternal physiological responses, relaxation therapy optimized blood pressure, heart rate and respiratory rate. Four trials showed relaxation therapy reduced duration of labour. Apgar score only improved significantly in two of six trials. One of three trials showed a significant increase in birth length, and one of three trials showed a significant increase in gestational age. Two of six trials examining delivery mode showed significantly increased spontaneous vaginal delivery and decreased instrumental delivery or cesarean section following a relaxation intervention.

Discussion

We found consistent evidence for beneficial effects of relaxation interventions in reducing maternal stress, improving mental health, and some evidence for improved maternal physiological outcomes. In addition, we found a positive effect of relaxation interventions on birth weight and inconsistent effects on other pregnancy or birth outcomes. High quality adequately powered trials are needed to examine impacts of relaxation interventions on newborns and offspring health outcomes.

Conclusion

In addition to benefits for mothers, relaxation interventions provided during pregnancy improved birth weight and hold some promise for improving newborn outcomes; therefore, this approach strongly merits further research.

Introduction

Stress, defined as “a state of mental discomfort, unpleasant feeling, worry or tension”, when occurring during pregnancy is a major public health problem in low- and middle-income countries (LMICs), associated with adverse maternal health, pregnancy and birth outcomes [1, 2]. Stress occurs when a demand to deal with internal or external cues/stressors exceeds the coping skills and resilience of individuals [3]. Common stressors during pregnancy include physical stressors, such as illness and discomfort, changes in lifestyle, poor social support, unplanned pregnancy, low financial income, role transitions, hormonal and physiological changes, anticipation of labour and delivery, and intimate partner violence during and after pregnancy [4, 5]. Stress can be acute, episodic/transient or chronic, depending on the type and nature of stressors [6].

The human body stores unresolved psychological stress in the musculoskeletal system, mainly in the scalp, neck, back, chest, abdomen and extremities [7]. This can result in sustained contraction of the muscles which interferes with normal physiological functions [7]. The resulting stress response in the body involves psychological (mental, emotional or behavioral) and/or physiological responses (blood pressure, heart rate, respiratory rate and body temperature) [8]. Biologically, stress activates the Hypothalamus-Pituitary-Adrenal (HPA) axis and the immune system through which it increases circulating glucocorticoids and pro-inflammatory markers [8]. Stress-induced glucocorticoid in the brain interferes with normal neurogenesis and synaptic plasticity leading to impaired functions of the nervous system which can result in mental illness [911]. This is recognized as the body-mind connection [1214] whereby the body and the mind work together to maintain optimal psychological equilibrium and physiological homeostasis.

Stress during pregnancy can negatively impact maternal health and well-being [15] and generally increases the risk of non-communicable diseases such as hypertension, diabetes, cardiovascular problems, anxiety and depression [16]. Nearly one in three women globally [17], and more than half of women in LMICs experience stress during their pregnancy [1720]. In Ethiopia, pregnant women experience higher levels of psychological stress compared to non-pregnant women and also exhibit lower resilience [18]. Globally, 15 to 25% of women experience high levels of anxiety or depressive symptoms during pregnancy [21, 22], with higher estimates from studies conducted in LMICs [22, 23]. Stress during pregnancy can affect the maternal immune system and increase the risk of infection and inflammatory diseases leading to maternal physical ill-health during and after pregnancy [8]. Antenatal stress and maternal mental disorders can adversely affect normal growth and development of the fetus and result in unfavorable pregnancy, obstetric and birth outcomes [15, 23, 24]. It can also influence the post-natal physical, mental and neurobehavioral health of the offspring, potentially leading to an increased risk of non-communicable diseases including mental illness later in life [24].

Several intervention modalities, including psychotropic medications, relaxation therapy and psychosocial and counseling therapies have been tested to reduce stress and improve the mental health of pregnant women [25]. Treatment of anxiety or depression with psychotropic medications during pregnancy or lactation carries potential risks for the mother and her offspring and has low acceptability [25]. Thus non-pharmacological interventions, such as counseling or relaxation therapies, are preferred for stress management during pregnancy [26, 27]. However, no comprehensive review of evidence is available on the effectiveness of relaxation interventions provided during pregnancy on maternal and neonatal health outcomes. This paper therefore aimed to systematically synthesize evidence on the effects of relaxation interventions on maternal stress and mental health during pregnancy and on pregnancy and birth outcomes.

Methods

Protocol registration

The protocol for this review was registered at PROSPERO International prospective register of systematic reviews and can be accessed at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020187443.

Article selection

The review process followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guideline [28]. To identify relevant articles, a three-step search strategy was employed. In the first step, key free text and MeSH terms were identified and developed. Then a comprehensive search was conducted in the following major databases: PubMed, EMBASE Classic + EMBASE (Ovid), MEDLINE in-process and non-indexed citations, MEDLINE daily, and MEDLINE (Ovid), Cumulative Index to Nursing & Allied Health Plus (CINAHL via EBSCO) and the Cochrane library. In addition, a manual search was conducted to identify further relevant studies from the reference lists of identified studies. Unpublished and grey literature were excluded.

The search terms were developed with a combination of key words relating to the study population, intervention types and outcome indicators, as follows. (“Pregnant women” OR “pregnancy” OR “prenatal” OR “prenatal care” OR “mother” OR “antenatal” OR “antenatal care” OR “maternal” OR “maternal care”) AND (“Relaxation therapy” OR “Mindfulness therapy” OR “Progressive muscle relaxation (PMR) therapy” OR “Music therapy” OR “Exercise therapy” OR “deep breathing relaxation therapy” OR “Meditation therapy” OR “hypnosis therapy” OR “relaxation lighting”), AND ("Stress" OR "distress" OR "anxiety" OR "depression" OR "Birth-weight" OR “birth weight” OR “birth outcome” OR “Apgar”, “Apgar score”, “Gestation”, OR “Gestational age at birth”).

Studies were eligible if they employed Randomised Controlled Trial (RCT) or quasi-experimental designs, applied a relaxation intervention during pregnancy or labour, were published in English, and reported one or more of the outcomes of interest specified in our search strategy. Observational studies (case reports, cross-sectional and cohort studies) and editorials or opinion pieces were excluded.

PICO

Population: apparently healthy pregnant women.

Intervention/exposure: stress reduction relaxation therapy. Any form of relaxation intervention, whether mind-based (tapes, music, meditation) or physical/body-based (massage, stretch or exercise) including progressive muscle relaxation (PMR) and deep breathing exercises, that were applied during pregnancy with the aim of reducing stress and promoting mental health.

Comparators/controls: pregnant women who did not receive a stress-reduction relaxation intervention but who received treatment as usual.

Outcomes: the main outcomes were measures of stress (self-report, physiological or biochemical), mental health problems (anxiety or depressive symptoms), obstetrics/pregnancy outcomes (gestational age, mode of delivery, duration of labour), birth outcomes (birth weight, birth length, Apgar score) and maternal physiology (vital signs).

Timing of outcome measures: studies that measured the outcome during, immediately after, or some weeks or months after the intervention were included.

Study screening process

The literature search was concluded on 26 August 2023. To decide on inclusion, the articles were first screened by title and then by abstract using the eligibility criteria. Full texts of the selected articles were then assessed based on the inclusion and exclusion criteria. Two authors (MA and BD) screened all articles for eligibility. Any queries were discussed with one additional author (AW) to reach a consensus. The screening process and reasons for exclusion are documented.

Methodological quality assessment

Two independent assessors (BD and MA) evaluated the methodological quality of studies in terms of randomization, masking and availability of descriptions for withdrawal and dropout of all participants based on the modified Jadad scoring scale [29] and the modified Delphi List Criteria [30] to assess the overall quality of the studies. Using the Cochrane Collaboration’s Assessment checklist [31], the risk of bias was assessed and rated as low, high or unclear for individual elements relating to five domains (selection, performance, attrition, reporting and other). The criterion on blinding was excluded as it is usually impossible to conduct relaxation therapy while blinding the participant or the care providers. S1 Table shows risk of bias assessment for all included studies.

Data extraction

The findings were extracted using a standard data extraction form prepared by the study team. Data were extracted in two phases. In the first phase, citation details (author name, publication year, design, sample size, setting, population, intervention, comparison and outcomes) were extracted. In the second phase, the intervention results by group were extracted.

Strategy for data synthesis

To obtain the pooled effects of the interventions, we conducted meta-analysis on the following outcomes for which there were an adequate number of studies with sufficiently ’similar’ outcomes that could be pooled meaningfully: maternal stress, anxiety, depressive symptoms and birth weight (BW). We used the mean difference (MD) with the reported Standard Deviation (SD) of the outcome as a measure of effect size for each of the included studies. For the meta-analysis, the raw mean difference (D), with 95% CI across studies that measured the same outcome (depression with Edinburgh Postnatal Depression Scale (EPDS) or stress with Perceived Stress Scale (PSS), anxiety with State-Trait Anxiety Inventory (S-TAS) and birth weight in grams) was examined and presented. Sub-group analyses were performed to examine the existence of significant differences among studies that used different relaxation methods for any given outcome of interest. We assessed heterogeneity with the Cochrane’s Q test and tau-squared (T2) and measured inconsistency (the percentage of total variation across studies due to heterogeneity) of effects across relaxation interventions using the I2 statistic. Publication bias was assessed using regression based on Egger’s test. For all meta-analyses, random effects model using restricted maximum likelihood estimates (REML) were employed. Statistical significance was defined as P < 0.05. Stata version 16 software (College Station, Texas 77845 USA) was used for the meta-analyses and for visualizing the forest plots.

For outcomes where meta-analysis was not possible because of inadequate number of studies and small sample size, a narrative synthesis of the reviewed articles on the effect of the interventions on each outcome of interest was performed and reported. S2 Table shows the preferred reporting items for systematic review and meta-analysis we followed to report the findings.

Results

Search results: Final reviewed studies

A total of 32 studies were included in the systematic review. See Fig 1 for the flow diagram.

Fig 1. PRISMA flow chart showing literature search results and study selection process.

Fig 1

Four of the reviewed studies were quasi-experimental [3235] and one was a non-randomized clinical trial [36]. The remaining 27 studies were RCTs. Among the 27 RCTs, 9 trials reported on maternal perceived stress during pregnancy using PSS [3745], 13 trials reported on anxiety during pregnancy using the State-Trait Anxiety Inventory (S-TAI) [37, 38, 40, 42, 4553], 7 trials reported on antenatal and postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS) [32, 38, 44, 48, 49, 51, 54], and 8 trials reported on birth weight in grams or kilograms [33, 51, 5560]. In addition, two trials reported the effects of antenatal relaxation on postnatal stress, anxiety and depression using the Depression, Anxiety and Stress Scale (DASS) [32, 34], three trials reported symptoms of maternal anxiety during labour and 24 hours postnatal using the Visual Analogue Scale for Anxiety (VAS-A) [54, 55, 61] and one trial reported anxiety using the pregnancy-related anxiety questionnaire [62]. Six trials reported on Apgar score [33, 51, 5557, 60], three trials reported on gestational age (GA) [51, 58, 60], six trials reported on mode of delivery [33, 5052, 55, 58], and four trials reported on duration of labour [50, 52, 55, 57].

Study context/settings

Four of the studies were from a lower middle-income countries (India = 3, Egypt = 1), 14 from upper-middle-income countries (China = 1, Thailand = 1, Indonesia = 1, Turkey = 2, Malaysia = 3, Iran = 6), and 14 were from high-income countries (HIC; United States of America = 2, United Kingdom = 1, Germany = 1, Switzerland = 1, Greece = 1, Spain = 3, Taiwan = 5).

Trials examining outcomes of maternal stress, anxiety or depressive symptom were from USA = 2, UK = 1, Switzerland = 1, Greece = 1, Turkey = 2, China = 1, Spain = 2, India = 3, Egypt = 1, Indonesia = 1, Malaysia = 2, Iran = 4 and Taiwan = 5. Trials on birth outcomes were from India = 1, Turkey = 1, Thailand = 1, Malaysia = 1, Spain = 1 and Iran = 3. There were no published studies from sub-Saharan Africa or from other Low-Income Countries (LIC).

Risk of bias within and across studies

Most studies had a low risk of selection, random allocation, concealment or other sources of bias. However, most studies had unclear risks on reporting bias (selective reporting of outcomes). S1 Table shows the risk of bias assessment findings for each of the studies.

Characteristics of relaxation methods

The reviewed articles used one or a combination of the following relaxation methods: yoga = 5, music = 12, PMR/BR = 8, mindfulness = 4, hypnosis = 3, Benson relaxation with music = 1 and Benson relaxation alone = 1. The duration of interventions ranged from as short as a 10-minute brief experimental intervention to 6 months of daily relaxation practice. Table 1 provides a detailed description and summary of information on the included studies.

Table 1. Description and summary of the results of the studies included in the systematic review and meta-analysis.

Authors, year Study size Country Design Relaxation, type and duration applied Time outcome measured Outcome Results
Relaxation Control
1. Bastani F, et al. 2005 EG:55
CG:55
Iran RCT Progressive muscle relaxation (PMR) and breathing exercise for 7 weeks between gestational age of 14 and 28 weeks Immeditely before and after the 7th week of intervention. Made goup comparison Stress—percieved stress scale (PSS) PSS points 24.4 ± 5.8 37.5 ± 5.7*
State anxiety—state anxiety trait inventory (S-STAI) S-STAI points 22.7 ± 7.4 38.5 ± 5.7*
Trait anxiety: (T-STAI) T-STAI, points 22.7± 7.4 38.5 ±5.7*
2. Bastani F, et al. 2006 EG:55
CG:55
Iran RCT Progressive muscle relaxation (PMR) and breathing exercise for 7 weeks between gestational age of 14 and 28 weeks Immeditely before and after intervention and at birth done for goup comparisons Birth weight (BW) grams 3168 ± 42 2883 ± 6*
Low BW n (%) 3 (5.8) 14 (26.9)*
Gestational age week 38 ± 5.9 38 ± 4.40
Preterm birth n (%) 1 (1.9) 5 (9.8) ‡
Mode of delivery; n (%) Abnormal 11 (21.2) 25 (48.1)*
SVD 41 (78.8) 27 (39.7)*
C/S 8 (15.4) 21 (40.40)*
Instrumental 3 (5.8) 4 (7.70)*
3. Chuntharapat S, et al. 2008 EG:33
CG:33
Thailand. RCT Yoga 1 hour weekly for 6 Weeks at 26–28th, 30th, 32nd, 34th, 36th, and 37th week of gestation After intervention (at birth) for group comparison Birth weight grams 3076.8±311.2 3125.5±287.4
Apgar score, 1st minute ≤7; n (%) 2 (6.1) 5 (15.2)
8–10; n (%) 31 (93.9) 28 (84.8)
Apgar score, 5th minutes ≤7; n (%) 0 0
8–10; n (%) 33 (100) 33 (100)
Length of labour, Minute First stage 520 ± 19 660 ± 27*
Second stage 27 ± 15 31 ± 14
Total labour 559 ± 20 684 ± 28*
4. Chang MY, et al. 2008 EG:
116
CG:
120
Taiwan RCT Music Therapy provided daily for 2 weeks Pre/post difference for group comparison Stress: PSS, points Pretest 17·4 ±4·6 16·7 ±4·3
Posttest 15.3 ± 5.2 15.8 ± 6.0
Pre-post diff. -2.1 -0.9*
Anxiety: S-STAI, points Pretest 37·9 ±9·8 37·1±10·0
Posttest 35.8 ± 10.9 37.8 ± 12.1
Pre-post diff -2.1 0.7*
Depression -Edinburg postnatal depression scale (EPDS), points Pretest 12·1±3·5 12·2±3·9
Posttest 10.3 ± 4.1 12.1 ± 4.6
Pre-post diff. 1.8 0.1*
5. Satyapriya M, et al. 2009 EG:45
CG:45
India RCT Yoga daily in the 2nd and 3rd trimester Pre/post difference for groups comparison Stress: PSS points, group difference 20th week of pregnancy 15.9 ± 5.0 15.4±5.7
36th week of pregnancy 10.9 ± 4.9 17.3±5.3*
Pre-post diff 5.0 -1.9*
6. Yang M, et al. 2009 EG:60
CG:60
China RCT Music therapy for 30 minutes on 3 consecutive days at admission for expected preterm birth Pre/post difference for group comparison Anxiety: STAI points, mean for pre/post and mean and SD for the pre/post difference reported Pretest 40.7 41.9
Posttest 26.6 41.8*
Pre-post diff. -14.1±5.8 -0.1±2.8*
7. Urech C, et al. 2010 EG1:
13
EG2:
13
CG:13
Switzerland RCT Progressive Muscle relaxation and Guided imaginary experiment applied for 10 minutes only Pre/post State anxiety: S-STAI Groups did not differ significantly in change of state anxiety from pre to post intervention. Anxiety decreased equally in all three groups from pre- to post-relaxation,F(1,35) = 5.14, p = .030*, d = .38
8. Liu YH, et al. 2010 EG:30
CG:30
Taiwan RCT Music therapy for 1 hour during labour Posttest for group comparison Labour anxiety using Visual Analogue Scale (VAS-A), points Latent phase 6.4 ± 3.0 5.2 ± 2.2
Active phase 8.2 ± 2.3 7.7 ± 2.1
Latent and active phase diff. -1.8 2.5*
9. Simavli S, et al. 2014 EG:67
CG:65
Turkey RCT Music therapy during labour Pre/post for group comparison Labour anxiety: VAS-A, points Pretest 2.8±0.4 2.7±0.4
Latent phase 4.3 ± 0.8 5.1 ± 0.9*
Active phase 8.47 ± 0.7 9.4 ± 0.7*
Second phase 9.1 ± 0.6 9.8 ± 0.4*
2 h after delivery 1.7± 0.3 4.2 ± 0.8*
Birth weight G 3375 ± 245 3420 ± 239
Apgar 9/10 n (%) 67 (100%) 61 (93.8%) +
Duration of labour, Minutes Latent phase 162 ± 15 164 ± 15
Active phase 189 ± 28 198 ± 15*
Second phase 83 ± 13 89 ± 18*
Third stage 17 ± 50 17 ± 5
Mode of delivery; n (%)
χ2 test, P>0.05
Caesarian section 5 (6.9) 9 (12.2)
Instrumental 2(2.7) 5 (6.8)
Spontaneous vaginal delivery 65 (90.2) 60 (81.0)
Episiotomy 51 (76.1) 52 (80.0)
Latent phase labour SBP, mm Hg 106.0±13.1 110.2±9.3*
DBP, mmHg 66.3±4.9 68.3±3.8*
Hear rate 76.0±4.8 78.7±5.9*
Active phase labour SBP, mm Hg 99.7±12.3 108.3±10.6*
DBP, mmHg 62.7±5.1 68.3±3.8*
Hear rate 74.4±4.9 78.7±5.8*
Second stage labour SBP, mm Hg 91.6±16.1 101.1±9.1*
DBP, mmHg 60.6±2.4 59.9±11.5
Hear rate 73.9±3.8 76.5±3.7*
2 h postpartum period SBP, mm Hg 94.2±5.0 99.9±15.5*
DBP, mmHg 59.4±2.4 63.4±10.7*
Hear rate 72.1±3.9 75.4±10.4*
10. Simavli S, et al. 2014 EG:71
CG:70
Turkey RCT Music therapy during labour Posttest group comparison Antenatal depression: EPDS Mean (SD) score 8.0 (2.8) 8.5 (2.6)
EPDS≥10, n (%) 18 (25.4) 21 (30.0)
EPDS≥13, n (%) 8 (11.3) 9 (12.9)
Postnatal depression day 1 Mean (SD) score 7.3±2.4 8.3±2.8*
EPDS≥10, n (%) 11 (15.5) 22 (31.4)*
EPDS≥13, n (%) 4 (5.6) 12 (17.1)*
Postnatal depression: EPDS, day 8 EPDS, points 7.1±2.1 8.6±2.9*
EPDS≥10, n (%) 9 (12.7) 25 (35.7)*
EPDS≥13, n (%) 4 (5.6) 13 (18.6)*
Postnatal Anxiety: VAS-A VAS-A (1 h) 3.3±0.5 4.9±0.9*
VAS-A (4 h) 2.7±0.4 4.2±0.8*
VAS-A (8 h) 2.3±0.3 3.3±0.5*
VAS-A (16 h) 1.7±0.3 2.8±0.4*
VAS-A (24 h) 0.9±0.6 2.3±0.3*
11. Tragea C, et al. 2014 EG:31
CG:29
Greece RCT Breathing and progressive muscle relaxation 1–2 times a day for 6 weeks Pre/post difference for group comparison Stress: PSS, points Pre-post diff. −3.7±1.8 −0.5±1.8*
Anxiety: S-STAI Pre-post diff. -3.5±2.8 -2.0±2.9
Anxiety: T-STAI Pre-post diff. -3.8 (1.4) -1.6 (2.5)
12. Guardino CM, et al. 2014 EG:24
CG:23
USA RCT Mindfulness training Pre/post (immediate posttest and 6 weeks after post test PSS, points: Significant main effect of time: p < 0.05* Pretest 41.8±6.0 39.9±8.6
Posttest immediate 37.3±5.4 35.8±8.0
Posttest 6 weeks 36.2±5.9 37.4±7.3
Anxiety: S-STAI: Significant main effect of time: p = 0.001* Pretest 45.7±7.6 44.4±11.0
Posttest immediate 39.7±6.3 37.4±11.5
Posttest 6 weeks 38.1±8.8 36.2±10.8
13. Newham J, et al. 2014 EG:29
CG:22
UK RCT Yoga training and practice applied for 8 weeks Pre/post difference for group comparison Anxiety: S-STAI, Points, medians (IQR) Baseline 28(24–42) 32 (24–37)
End line 27(22–36) 34 (25–38)
Anxiety: T-STAI, Points, medians (IQR) Baseline: 34 (29–40) 35 (33–39)
End line: 34 (29–39 34 (30–41)
Depression: EPDS, Points, medians (IQR) Baseline: 5 (2–10) 5 (4–8)
End line: 4 (2–7) 6 (3–10)*
Anxiety: WDEQ Baseline: 74 (62–87 77 (60–85)
End line: 61 (42–77) 69 (58–78)*
14. Davis K, et al. 2015 EG:23
CG:23
USA RCT Yoga for 8 weeks Pre/post, and midline assessment Depression: EPDS, points Baseline 10.1 ± 4.5 10.6±5.1
Midline 8.5 ± 4.9 8.8 ±6.0
End line 6.4 ± 4.0 7.3 ± 5.1
Baseline-end line mean diff. 3.7 3.3
Anxiety: S-STAI), points Baseline 36.9 ±12.2 41.7±10.8
Midline 41.8±15.2 39.0±11.4
End line 34.8±10.7 38.8 ±13.7
Baseline-end line mean diff. 2.1 2.9
Anxiety: T-STAI, points Baseline 45.0 ±12.1 45.4 ±10.2
Midline 43.1 ±11.4 42.4±13.5
End line 38.4 ±9.9 40.4±10.9
Baseline-end line mean diff. 6.6 5
15. Chang HC, et al. 2015 EG:
145
CG:
151
Taiwan RCT Music therapy during 2nd and / or 3rd trimester Pre/post for pre-post mean difference for group comparison Stress: PSS, points Pretest 16.5±4.9 16.4±4.8
Posttest 16.0 ±5.6 16.4 ±5.3
Pre-post diff. 0.5 0
STRESS: Pregnancy Stress Rating Scale (PSRS) Pretest 53.7±24.1 49.9±22.3
Posttest 54.0±23.6 54.9±22.7
Pre-post diff. 0.3 4.8*
16. Liu YH, et al. 2016 EG:61
CG:60
Taiwan RCT Music therapy for 2 weeks Pre/post Stress: PSS, points Pretest: 17.1 ± 5.4 16.3 ± 5.2
Posttest: 17.9 ± 4.1 19.3 ± 2.5
Pre-pots mean diff. for group comparison -0.8 -3.0*
Anxiety: S-STAI, points Pretest 39.7 ± 10.7 40.2 ± 10.2
Posttest 37.3±10.0 42.1±11.6
Pre-pots mean diff. group comparison 2.4 -1.9*
17. Muthukrishnan S, et al. 2016 EG:37
CG:37
India RCT Mindfulness Meditation for 4 weeks from 13–16 gestational week 5 weeks after enrollment (at 17–18 weeks of gestation) Stress: PSS, points Posttest between group comparison 19.1±1.4 32.1±2.40*
BP: mmHg SBP 109.22±3.8 124.68±5.6*
DBP 69.11±2.23 69.11±2.2
Hear rate variability Beats/min 26.59±2.1 20.65±1.5*
Respiratory rate Breath/minute 18.08 ±1.8 19.27±2.1*
Cold Pressor systolic blood pressure response. 9.68±1.8 13.38±2.23*
Cold Pressor diastolic blood pressure response. 4.19±0.98 7.54±1.4*
Mental arithmetic systolic blood pressure response. 8.97±2.21 13.49±3.1*
Mental arithmetic diastolic blood pressure response. 5.22±1.53 4.38±1.32 +
18. Beevi Z, et al. 2016 EG:28
CG:28
Malaysia Quasi-experimental Hypnosis practiced since 16 week of gestation Pre/post: Stress: DASS-21, points at 36 weeks of gestation Posttest mean group difference (raw data not given) 5.8 ±5.4 10.7 ±8.9*
F (1,44) = 4.70, p = 0.03, partial ŋ2 = .101*
Anxiety: DASS-21, points at 36 weeks of gestation Posttest mean group difference (raw data not given) F(1,44) = 10.76,p = 0.01, partial ŋ2 = 0.20*
Depression: DASS-21, points at 36 weeks of gestation Posttest mean group difference F(1,16) = 0.958,p = 0.342, partial ŋ2 = .06.
19. Beevi Z, et al. 2017 EG: 23
CG: 22
Malaysia Quasi-experimental Hypnosis provided at 16, 20, 28, and 36 weeks of their pregnancy and advised to practice every day until labour Posttest / done at birth Birth weight, g 3103.5±301.2 3070.9±367.24
SVD, n (%) 19 (42.2) 14 (31.1)
C/S, n (%) 4 (8.9) 8 (17.8)
Apgar score at 1 minute, % 5 0 4.3
6 0 4.3
8 4.3 18.2
9 95.7 72.7 *
Apgar score at 5 minute 9 0 4.5
10 100 95.5
20. Gonzalezet al. 2017 EG:
204
CG:
205
Spain RCT Music therapy for 40 minutes daily for 2 weeks Posttest for group comparison Birth weight Kg 3.4±0.4 3.4±0.5
Newborn length Cm 50.3±1.86 50.6±2.0
head circumference Cm 34.5±1.3 34.6±1.4
Apgar score 1 minute, 9.1±0.8) 9.0±0.9
Apgar score 5 minute, 9.9±0.3 9.9±0.4
21. Novelia S, et al. 2018 EG:15
CG:15
Indonesia Quasi experimental Yoga 2 times in 2 weeks each lasting 90 minutes Posttest group comparison: Anxiety (Anxiety: Hamilton Anxiety Rating Scale), n (%): (t = -9.83, p = 0.01)* Yes 2 (13.3%) 15 (100%)
No 13 (86.7%) 0 (0%)
22. Gonzalez et al. 2018 EG:
204
CG:
205
Spain RCT Music therapy for 40 minutes daily for 2 weeks Posttest group comparison Onset of labour
n (%),p < 0.01*
Spontaneous 140 (68.63) 111 (54.2)
Stimulated 5 (2.5) 12 (5.9)
Induced 59 (28.9) 82 (40.0)
Mode of delivery; n (%),P = 0.58 Vaginal 155 (75.9) 151 (73.7)
C/S, n (%) 49 (24.02) 54 (26.3)
Labour duration First stage, hours 4.36 ±3.7 5.54 ±4.8*
State-Trait-Anxiety (STA); posttest, group comparison STA, points 30.6±13.2 43.1 ±15.0*
23. Beevi Z, et al. 2019 EG:28
CG:28
Malaysia Quasi-experimental Hypnosis provided at 16, 20, 28, and 36 weeks of their pregnancy and advised to practice every day until labour 2 month postnatal mean (SD) difference for group comparison Stress: DASS-21 5.5±5.1 3.6±5.1
Anxiety: DASS-21 2.9±3.0 38.4± 58.8*
Depression: DASS-21 1.3± 2.4 6.7± 5.7*
Depression: EPDS 5.7±2.8 10.6±4.0*
24. Pan Win Lan, et al. 2019 EG:39
CG:35
Taiwan RCT Mindfulness based Programs: Once every week for 8 weeks Baseline and 3mo postpartum, mean (SD) Stress: PSS, points Pretest 15.4(5.7) 13.8(6.0)
Posttest 11.6 ± 6.1 14.3 ±5.2
Pre-post diff 3.8 0.5*
Depression: EPDS, points Pretest 9.5±4.0 8.7±4.5
Posttest 6.5 ± 4.5 8.8 ±3.4
Pre-post diff 3 -0.1*
25. Ahmadi M, et al. 2019 EG:75
CG:75
Iran RCT Progressive muscle relaxation/PMR Posttest between group comparison Length at birth CM 52.1±3.6 48.6±3.4*
Birth weight G 3400±0.5 3200±0.6*
Postpartum depression, day 1 Zung’s Self-rating Depression Scale 56.5±0.5 57.1±0.6
Postpartum depression, day 3 Zung’s Self-rating Depression Scale 49.7±0.4 59.4±0.7*
Postpartum depression, day 10 Zung’s Self-rating Depression Scale 44±0.4 60.3±0.8*
26. Rajeswari S, et al. 2020 EG:
120
CG:
119
India RCT Progressive Muscle Relaxation daily practice from 21/22 weeks of gestation until delivery Posttest group comparison Stress: Calvin Hobel scale:
P < 0.001*
Minimal; n (%) 0 (0.00) 0 (0.0)
Mild; n (%) 51 (41.6) 19 (15.2)
Moderate; n (%) 67 (54.4) 71 (56.8)
Severe; n (%) 5 (4.00) 35 (28.0)
Overall stress; 40.5 ±8.6 77.6 ±8.9*
Anxiety (S-STAI)
Fisher exact test: F3 = 17.80, P < 0.001*
Minimal; n (%) 0 (0.0) 0 (0.0)
Mild; n (%) 22 (17.9) 9 (7.2)
Moderate; n (%) 97 (78.9) 84 (67.2)
Severe; n (%) 4(3.2) 32 (25.6)
Anxiety (T-STAI)
Fisher exact test: F3 = 18.60, P < 0.001*
Minimal; n (%) 0 (0.00) 0 (0.0)
Mild; n (%) 24 (10.0) 10 (8.0)
Moderate; n (%) 95 (83.0) 83 (66.4)
Severe; n (%) 4 (3.0) 32 (25.6)
Overall anxiety: (STAI)
Fisher exact test: F3 = 19.80, P < 0.001*
Minimal; n (%) 0 (0.0) 0 (0.0)
Mild; n (%) 26 (11.0) 11 (8.8)
Moderate; n (%) 93 (82.0) 82 (65.6)
Severe; n (%) 4 (32.0) 32 (25.6)
Postpartum depression EPDS, points 6.9 ± 2.5 10.5 ±2.7*
Gestational age, n (%)
P = 0.01*
Before 37 weeks 14 (11.5) 25 (20.3)
After 37 weeks 108 (88.5) 98 (79.7)
Gestational age (weeks) 38.0±3.6 37.2±4.2*
Apgar score; n (%); fisher exact test: P = 0.06 0‑3 0 (0.0) 3 (2.4)
4–6 2 (1.7) 10 (8.2)
7–10 120 (98.3) 110 (89.4)
Apgar score Score/10 8.3 ±0.2 8.0 ±0.6
Birth weight Kg 2.7 ±0.4 2.6 ±0.5*
Mode of delivery
n (%): P = 0.001*
Normal vaginal 90.0 (74.2) 61.0 (49.6)
Assisted vaginal 5.0 (4.0) 12.0 (9.8)
C/S 27 (21.8) 50 (40.60)
Induced labour
P = 0.019*
Yes, n (%) 110(9.0) 23 (20)
No, n (%) 111 (91.0) 100 (80.0)
Hypertension
P = 0.037*
Yes, n (%) 4 (3.0) 12 (10.0)
No, n (%) 118 (97) 111 (90)
27. Zarenejad M, et al. 2020 EG:30
CG:30
Iran RCT Mindfulness: 6 group counseling sessions twice a week, and each session lasted for 60 min Posttest group comparison Pregnancy-Related Anxiety:
Posttest between group difference
P = 0.001*
Pretest, 182.9 ± 74.2 195.1 ± 42.9
Posttest immediate 154.5 ± 61.8 187.9 ± 41.5
Posttest 1 month later 124.9 ± 45.5 182.5 ± 41.7
28. Abd Elgwad FMH, et al. 2021 EG:40
CG:40
Egypt Non-randomized controlled clinical trial Benson’s Relaxation twice daily (separated by 3 hours) for 3 days Posttest group comparison Stress: PSS, n (%) Immediate posttest: P = 0.01* Yes 25 (62.5) 40 (100)
No 15 (37.5) 0 (0)
Posttest after 3 days: P = 0.01* Yes 10 (25) 40 (100)
No 30 (75) 0 (0)
Blood pressure: mmHg SBP: Pretest 158.3±12.2 150.5±18.8*
SBP immediate posttest 144.1±12.1 145.1±17.1
SBP 3 days posttest 119.3±3.3 145.1±17.1*
DBP pretest 95.2±11.2 90.8±12.2*
DBP immediate posttest 87.8±9.5 87.4±9.8
DBP 3 days posttest 77.0±4.6 87.4±9.8*
Heart rate, Pretest 92.3±7.2 97.8±16.3+
Immediate posttest 87.4±6.1 93.1±10.0*
3 days posttest 81.2±3.8 93.1±11.0*
Respiration rate Pretest 21.45±2.2 22.8±2.9*
Immediate posttest 20.7±1.2 22.4±2.7*
3 days posttest 18.6±1.2 22.4±2.7*
29. Bauer I, et al. 2021 EG1: 12
EG2:
12
CG:
12
Germany RCT
(3-arm, parallel-group)
EG1: Music EG2: Guided imagery (GI)
CG: Resting
Provided for 20 minute during labour
Pre/post Indicators Music group GI group Control group
Cardiovascular activity on heart rate, 5 minutes posttest −2.33±2.9 −1.9±1.8 −2.4±(3.4
Cardiovascular activity on heart rate, 10 minutes posttest − 2.5±5.6 −1.4±3.0 −2.6±4.3
Heart rate variability No significant group effect, F(2,94)  =  0.624, p  =  .538
Skin conductance 5 minute posttest 0.01±0.1 0.2± 0.7 −0.1± 0.5
Skin conductance 10 minute posttest −0.04±0.2 −0.7±1.5 −0.1±0.6
30. Estrella-Juarez F, et al. 2022 EG1:
104
EG2:
124
CG: 115
Spain RCT
3-arm parallel group
EG1:Music therapy and EG2: Virtual reality (VR) intervention during labour Pre/post Outcomes Music VR Control
First stage of labour, h 4.7±4.1 4.3±3.1 6.3±5.2*
Spontaneous labour n (%) 50 (48.1) 103 (82.4) 59±51.8*
Induction labour, n (%) 54 (51.9) 22 (17.6) 55 (48.2)*
SVD, n (%) 49 (47.1) 73 (58.4) 56 (49.1)
Instrumental assisted, n (%) 21 (20.2) 32 (25.6) 26 (22.8)
C/S, n (%) 34 (32.7) 20 (16) 32 (28.1)
Pretest T-STAI 19.0± 6.9 19.2±7.1 19.8±7.4
Posttest T-STAI 12.6±6.0 12.4±5.9 19.2±9.0
Pre-post mean diff. (within group comparison) 6.4* 6.8* 0.6
Pretest S-STAI 16.3±5.8 16.6±6.8 16.5±4.8
Posttest S-STAI 14.7±3.3 15.2±3.3 17.6 ±7.2
Pre-post diff (between group comparison) 1.6 1.3 −1.1
SBP 106.9±8.3 108.3±9.8 115.9±11.4*
DBP 69.9±7.3 70.4±7.9 75.0±8.9*
Heart rate 79.2±8.4 79.8±7.9 83.0±10.4*
31. Abarghoee SN, et al. 2022 EG1:
35
EG2:
35
CG:35
Iran RCT
(A parallel, three-armed)
Benson Relaxation Technique (BRT) and Music Therapy (MT)  Pre/post within and between group comparison Anxiety: S-STAI; Pre-post difference within group comparison BRT group MT group CG
Pre: 50.6±1.3 49.4±1.6 50.3±1.4
Post: 42.3±1.3 43.1±1.2 48.3±1.7
diff: 8.3* diff: 6.3* diff: 2.0
Anxiety (S-STAI) pre/post between group comparison Pre: 50.6±1.3 49.4±1.6 50.3±1.4
Post: 42.3±1.3 43.1±1.2 48.3±1.7*
32. Ghorbanneja d S, et al. 2022 EG: 44
CG: 44
Iran RCT Jacobson’s progressive muscle relaxation Posttest between group comparison Birth weight G 2863.5±176.0 2762.7±202.1*
Birth length CM 47.8±2.1 47.5±2.2
HC CM 34.7±0.2 34.5 0.1
Gestational age Week 36.3±0.7 36.2±0.8
Apgar score 1st min 9.0±0.4 8.8±0.3
BP: mmHg SBP 137.6±3.9 147.5±5.0*
DBP 88.7±3.8 99.2±4.5*
FBS Mg/Dl 101.8±6.8 111.0±9.5*

Abbreviations: ACTH, Adrenocorticotropic hormone; BP, Blood pressure; CG, CM, Centimeter; Control group; C/S: Cesarean section; DASS-21, Depression, anxiety, stress scale- 21 items version; DBP, Diastolic blood pressure; EG, Experimental group; EPDS, Edinburgh postnatal depression scale; FBS, Fasting blood glucose; h, hour; HR, Heart rate; GI, Guided imaginary; IQR, Inter-quartile range; Kg, Kilogram; mg/dL, milligram per deciliter; Mo, Month; PSS, Perceived stress scale; Pre, pretest, post, posttest, diff, difference; RCT, Randomized control trial; SBP, Systolic blood pressure; SD, Standard deviation; S-STAI-S, State-trait anxiety inventory–state version; T-STAI, State-trait anxiety inventory–trait version; SVD, Spontaneous vaginal delivery; VAS, Visual analogue scale; WDEQ, Wijma delivery expectancy questionnaire–modified version.

Note

* P < 0.05

+ p = 0.05

‡ P ≥ 0.05

Intervention outcomes

Maternal mental health

The effects of relaxation interventions on maternal mental health was examined in relation to symptoms of stress, anxiety or depression during the antenatal or postnatal periods.

Maternal stress. Nine trials (one of which reported stress at two time points) reported on the effectiveness of relaxation therapy on maternal stress symptoms using the PSS [3745] and 2 trials using the DASS scale [32, 34]. Interventions applied were music therapy, meditation, mindfulness-based childbirth and parenting program, yoga, hypnosis, and PMR/BR.

A meta-analysis of the 9 trials (n = 1160 participants) using PSS mean and SD showed that relaxation interventions during pregnancy had a significant effect on reducing maternal perceived stress during pregnancy (overall mean difference (MD): -4.1; 95% CI: -7.4, -0.9)). In a subgroup analysis, only music therapy as a group significantly reduced maternal stress (MD: -.8, 95% CI: -1.53, -0.05), but not other relaxation methods. There was high level of heterogeneity among the studies (I2 = 97.8%, P<0.01). Output of the meta-analysis on stress is provided in Fig 2.

Fig 2. Forest plot and subgroup analysis for raw mean difference of studies on the effects of relaxation interventions on maternal stress measured using the perceived stress scale (PSS).

Fig 2

Maternal anxiety. Anxiety symptoms were reported in 13 trials [37, 38, 40, 42, 4553] using the STAI, two trials using the DASS [32, 34], three using the VAS-A scale) [54, 55, 61] and one using pregnancy related anxiety questionnaire [62].

Eleven of the 13 trials reported mean and SD using S-STAI (two of which reported anxiety at two time points). Meta-analysis of the 11 trials (n = 1965 participates) showed that relaxation interventions provided during pregnancy were effective in reducing symptoms of maternal anxiety (overall MD: -5.04; 95% CI: -8.2, -1.9). In a subgroup analysis, only music therapy as a group showed a significant effect in reducing anxiety by 6 points (MD: -5.8; 95% CI: -9.1, -2.4), but not other relaxation methods. The trials were highly heterogeneous (I2 = 97.1%, p<0.01). The output of the meta-analysis on anxiety is provided in Fig 3.

Fig 3. Forest plot and subgroup analysis for raw mean difference of studies on the effects of relaxation interventions on antenatal anxiety score using S-TAI.

Fig 3

The other 3 trials that were not included in the meta-analysis (because they did not reported mean and SD) were also effective in reducing symptoms of anxiety during pregnancy [34], labour [55, 61], and during the 24 hours [54] and 2 months postnatal [32] periods.

Maternal depressive symptoms. Seven trials examined effects of relaxation interventions provided during pregnancy on maternal depressive symptoms measured using the EPDS [32, 38, 44, 48, 49, 51, 54]. Specific relaxation methods included in this section were yoga, Mindfulness-Based Childbirth and Parenting (MBCP) Music and PMR interventions.

Six of the 7 trials reported mean and SD using EPDS (one of which reported depression at two time points). Meta-analysis of the six trials (n = 933 participants) using EPDS mean and SD showed that relaxation interventions during pregnancy are effective in reducing maternal depressive symptoms (overall MD: -2.3; 95% CI: -3.4, -1.3) in the intervention compared to the control group. In a subgroup analysis, Music therapy as a group showed association with reduced depressive symptoms (MD: -2.2; 95% CI: -3.8, -0.06). The trials were found to be heterogeneous (I2 = 83.4%, P<0.01). The effects of relaxation interventions in improving depression also persisted to immediate one week postnatal [55] and the two month postnatal [32] period. Output of the meta-analysis on depressive symptoms is provided in Fig 4.

Fig 4. Forest plot and subgroup analysis for raw mean difference of studies on the effects of relaxation interventions on depressive symptoms using EPDS.

Fig 4

Newborn outcomes

Birth weight (mean, SD) as an outcome was reported in 8 trials [33, 51, 5560]. The meta-analysis of the 8 trials (n = 1239 participants) indicated that relaxation interventions improved birth weight (overall MD = 80; 95% CI: 1, 157). Subgroup analysis showed that only PMR/BR, but not other relaxation methods, increased birth weight significantly (MD = 165; 95% CI: 100, 231) in the intervention compared to the control group. The subgroup analysis showed significant heterogeneity among the studies (I2 = 63.0%, P = 0.03). Output of the meta-analysis on birth weight is provided in Fig 5.

Fig 5. Forest plot and subgroup analysis for raw mean difference of studies on the effects of relaxation interventions on birth weight (g).

Fig 5

Apgar score as outcome was measured in 6 trials [33, 51, 5557, 60]. A study in Turkey reported 100% of neonates born to mothers in the relaxation group (music therapy) compared to 93.8% of neonates born to mothers in the control group scored 9/10 (p = 0.05) for Apgar score at 5 minute evaluation [55]. The trial in Malaysia reported a significant difference in Apgar score at 1 minute evaluation where 96% of neonates born to mothers in the relaxation (hypnosis) group scored 9 compared to 73% of neonates born to mothers in the control group [33]. The other trials showed no effect on Apgar score either at 1 or 5 minute evaluation [51, 56, 57].

Gestational age as an outcome was reported in three trials [51, 58, 60]. In India, relaxation significantly increased gestational age at birth (38.0 (±3.6) weeks in the relaxation group vs 37.2 (±4.2) weeks in the control group, p = 0.04). The same trial reported that the percentage of preterm births was significantly lower in the relaxation group (11.5%) compared to the control group (20.3%) (p = 0.01) [51]. However, studies in Iran reported no significant effect of relaxation therapy on gestational age, but the sample size for this trial was small [58, 60]. Newborn length at birth was reported in three trials; one of which reported increased birth length in the relaxation group (mean difference 3.5 centimetres; 95% CI: 2.4, 4.6) [59]; but not the remaining trials [56, 60].

Obstetric outcomes

Four RCTs assessed the effect of relaxation interventions on obstetric outcomes. In Turkey, women who received music therapy during labour had a significantly shorter mean (SD) duration of labour 189 (28) minutes in the first stage of active labour and 83 (13) minutes in the second stage of labour compared to 198 (15) minutes and 89 (18) minutes respectively in the control group [55]. In the same trial, women in the intervention group (music therapy) had non-significantly decreased rates of Cesarean section (6.8%), instrumental delivery (2.7%), episiotomy (76.1%), and non-significantly increased rate of spontaneous vaginal delivery (90.2%) compared to 12.2% cesarean section, 6.8% instrumental delivery, 81% episiotomy and 80% spontaneous vaginal delivery in the control group [55]. A study from Iran reported a significantly reduced rate of abnormal delivery in the relaxation (PMR/BR) group (21.2%) compared to 48.1%, p = 0.01, and an increased rate of spontaneous vaginal delivery (78.8%) compared to 39.7%, p = 0.01, in the control group [58]. Similarly, there was a significant improvement in spontaneous vaginal delivery (74.2% in the PMR/BR compared to 49.6% in the control group) and a decreased rate of Caesarian deliveries (21.8% in the PMR/BR compared to 40.6% in the control group) in India [51]. The same trial reported a significantly decreased rate of induced labour in the PMR/BR group compared to women in the control group (F2 = 5.50, p = 0.019) [51].

An RCT in Thailand also reported significantly shorter duration of first stage labour 520 (186) minutes vs. 660 (273) minutes (p<0.05) and shorter total duration of labour 559 (203) minutes vs 684 (276) minutes (p<0.05) in the yoga group compared to women in the control group [57].

Maternal physiological outcomes

Measurements of maternal physiological outcomes were reported in six studies [36, 43, 52, 55, 60, 63]. Pregnant women in the relaxation group had lower systolic and diastolic blood pressure, heart rate, respiration rate and skin conductance level activity during pregnancy, labour and the postnatal period [36, 43, 52, 55, 60, 63].

Discussion

In this systematic review and meta-analysis, we synthesized existing literature and provided up-to-date evidence on the effects of relaxation interventions during pregnancy on maternal mental health problems (stress, anxiety and depressive symptoms), and pregnancy and birth outcomes. Consistent beneficial impacts of relaxation interventions on mental health and birth weight outcomes were observed in terms of maternal stress, anxiety, depression and birth weight, although study heterogeneity was high. Furthermore, relaxation interventions consistently improved maternal physiological indicators during pregnancy and shortened the length of labour at birth. Findings on birth outcomes such as gestational age, mode of delivery, Apgar score and offspring birth length were mixed and non-conclusive. In subgroup analysis, music therapy has reduced symptoms of stress, anxiety and depression consistently and PMR/BR relaxation improved offspring birth weight. Several mechanisms such as brain stem reflex, arousal, inducing emotions, mental imagery, conjure episodic memory and evaluative conditioning, could be involved in music therapy to improve mental health [6466]. On the other hand, PMR/BR, through activation of cortical brain activities and by enhancing blood circulation and oxygen saturation, could optimize mental health and physiologic output [6770].

The meta-analysis indicated that relaxation interventions are effective in reducing stress during pregnancy. One underlying mechanism can be explained by the model of body-mind connection and integration [71] whereby body, mind, brain and behavior are all interlinked and influence one another [72, 73]. Psychological stress leads to sustained contraction of muscle tissues making them tense with increased vasoconstriction, blood pressure, heart rate and decreased circulatory outcomes until the stress is resolved. Physical relaxation methods, such as breathing and muscle relaxation, further contract and then relax the muscle to expel the newly induced stress along with the preexisting pathological stress from the body. Another mechanism is that psychological relaxations such as meditation and music therapies relax the mind, induce emotions, mental imagery, and counter unpleasant feelings and thoughts to improve mental wellbeing.

In addition to their effects on stress, the meta-analysis showed that relaxation interventions are effective in improving symptoms of anxiety and depression. This could be explained by the fact that anxiety and depression are mainly the consequence of increased and unresolved stress in human life [74, 75]. Increased level of stress activates the HPA axis as well as the sympathetic and parasympathetic nervous system [8, 74, 75] and influences the neuronal circuits responsible for regulating and mediating anxiety and depression in the brain [8, 74, 75]. Thus, by reducing stress, relaxation therapy could break the neurobiological links between stress, anxiety and depression. Another mechanism of relaxation is through its effect on improving neurogenesis, synaptogenesis and increased gray matter density and volume with potential benefit for optimizing neurotransmitters in the brain [76, 77].

In two trials in this review, the positive effects of relaxation in improving anxiety and depression persisted into the postnatal period. This enduring benefit of relaxation could arise because relaxation interventions prevent antenatal anxiety and depression which would otherwise persist into the postnatal period. Alternatively, the relaxation interventions provided during pregnancy may have a prolonged effect on maternal stress management and reduce the risk of anxiety and depression in the postnatal period. Improved maternal well-being during pregnancy helps the mothers to care for herself more optimally during pregnancy while persistence of better maternal mental health into the postnatal period could help mother-infant attachment, child care and exclusive breastfeeding, all of which promote positive growth and development of the offspring [78, 79].

Finally, in the meta-analysis, relaxation interventions showed a positive effect on birth weight of the newborn. This was entirely explained by the effect of progressive muscle relaxation and deep breathing on birth weight [51, 5860], whereas no effect was seen for music, hypnosis or yoga therapies [33, 5557]. This contrast could be because deep breathing and muscle relaxation rather than music therapy improve physical relaxation and optimized maternal physiology to improve uterine circulation, benefitting fetal growth and development. However, PMR/BR interventions were also given for longer periods compared to yoga and music therapies which could result in stronger effects compared to the other approaches.

In the narrative synthesis, studies that evaluated physiological responses found relaxation therapies to be effective in improving the physiology of pregnant women by optimizing vital signs such as blood pressure, heart rate, body temperature and respiration. Inconsistent effects of relaxation interventions on pregnancy and birth outcomes such as mode of delivery, gestational age, birth length and Apgar score were observed. The lack of associations in some of the outcomes could be because most of the reviewed studies were primarily powered to examine impacts on maternal mental health but not obstetric and birth outcomes. In addition, only a few trials reported gestational age and birth outcomes, compounded by a relatively small sample size.

In summary, the mechanisms through which relaxation interventions could improve maternal well-being, and pregnancy and birth outcomes could involve an interplay of physical, psychological and physiological mechanisms. Physical responses to relaxation include immediate musculoskeletal relaxation and a decrease in muscle tension; psychological responses include mental calmness, silence and peace; and physiological responses to relaxation include optimized blood pressure, heart rate, respiratory rate and metabolic rate, along with decreased stress hormones and increased blood circulation [8084]. Through one or a combination of these mechanisms, relaxation interventions could improve the health and well-being of pregnant woman, and this in turn may support fetal growth and development of the offspring.

Strengths and limitations

A strength of this work is that we included trials that applied different forms of relaxation interventions and undertook both descriptive/narrative as well as pooled meta-analysis based on data availability. However, the findings of the systematic review and meta-analysis also had some limitations. Most trials were primarily powered for maternal mental health, either stress, anxiety or depression, and not for pregnancy or birth outcomes. Because of lack of literature, some of the subgroup analysis involved only a single study. Furthermore, data on the effects of the relaxation interventions on neonatal outcomes other than birth weight were very limited and insufficient to conduct meta-analysis. Finally, most of the studies included in this review are from middle- or HIC and the findings might not be applicable for LIC settings, where both the sources of stress, and the feasibility of interventions, may be different.

Conclusion and recommendation

The results of this review indicate that, in addition to physiological and mental health benefits for mothers, relaxation interventions improved birth weight and hold some promise for improving other newborn outcomes; therefore, this approach strongly merits further research. Future research that is adequately powered on birth and newborn outcomes such as gestational age, birth weight and birth length is crucial. Considering the magnitude of perinatal maternal mental health and psychological problems, the high burden of obstetric complications and the associated global burden of maternal and neonatal morbidity and mortality, the results of this review indicate that a range of complementary interventions may help address these problems. Their relative cost-effectiveness, ease and absence of adverse and teratogenic effects in comparison to pharmacological treatments favours the application of one or a combination of these relaxation therapies in this population group. Relaxation interventions are low-intensity and may be more scalable than individualized psychological interventions in resource-limited settings.

Therefore, we recommend that these relaxation interventions be evaluated for their acceptability, suitability and effectiveness to improve maternal and offspring health outcomes in LICs. Further evaluating the interventions in these settings would also be beneficial to understand whether, in places with severe food insecurity and a high burden of infections, which affect both maternal and infant health, relaxation interventions could mitigate the harmful effects of stressors.

Supporting information

S1 Table. Quality assessment report for risk of bias for included studies in the review based on the Cochrane Collaboration’s risk of bias assessment tool.

(DOCX)

S2 Table. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

(DOCX)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

National Institute of Health Research through the NIHR Global Health Research Group - NIHR134325 - NIHR200842 Wellcome Trust - 222154/Z20/Z - 223615/Z/21/Z - Dr Charlotte Hanlon.

References

  • 1.Dunkel Schetter C, Tanner L. Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatry. 2012. Mar;25(2):141–8. doi: 10.1097/YCO.0b013e3283503680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alves AC, Cecatti JG, Souza RT. Resilience and Stress during Pregnancy: A Comprehensive Multidimensional Approach in Maternal and Perinatal Health. Cheng JT, editor. Sci World J. 2021. Aug 13;2021:1–7. doi: 10.1155/2021/9512854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Baqutayan SMS. Stress and Coping Mechanisms: A Historical Overview. Mediterr J Soc Sci [Internet]. 2015. Mar 1 [cited 2023 Aug 17]; Available from: https://www.richtmann.org/journal/index.php/mjss/article/view/5927 [Google Scholar]
  • 4.Fisher J, Cabral De Mello M, Patel V, Rahman A, Tran T, Holton S, et al. Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review. Bull World Health Organ. 2012. Feb 1;90(2):139–149H. doi: 10.2471/BLT.11.091850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Saur AM, Dos Santos MA. Risk factors associated with stress symptoms during pregnancy and postpartum: integrative literature review. Women Health. 2021. Aug 9;61(7):651–67. doi: 10.1080/03630242.2021.1954132 [DOI] [PubMed] [Google Scholar]
  • 6.McEwen BS. Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain. Physiol Rev. 2007. Jul;87(3):873–904. doi: 10.1152/physrev.00041.2006 [DOI] [PubMed] [Google Scholar]
  • 7.American Psychological Association (APA). Stress effects on the body. https://www.apa.org/topics/stress/body. Accessed: 8/17/2023.
  • 8.Godoy LD, Rossignoli MT, Delfino-Pereira P, Garcia-Cairasco N, De Lima Umeoka EH. A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications. Front Behav Neurosci. 2018. Jul 3;12:127. doi: 10.3389/fnbeh.2018.00127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. Chronic Stress Induces Contrasting Patterns of Dendritic Remodeling in Hippocampal and Amygdaloid Neurons. J Neurosci. 2002. Aug 1;22(15):6810–8. doi: 10.1523/JNEUROSCI.22-15-06810.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2012. Jan;13(1):22–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pittenger C, Duman RS. Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms. Neuropsychopharmacology. 2008. Jan;33(1):88–109. doi: 10.1038/sj.npp.1301574 [DOI] [PubMed] [Google Scholar]
  • 12.Berrios GE. Historical epistemology of the body-mind interaction in psychiatry. Dialogues Clin Neurosci. 2018. Mar;20(1):5–13. doi: 10.31887/DCNS.2018.20.1/gberrios [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Brower V. Mind–body research moves towards the mainstream: Mounting evidence for the role of the mind in disease and healing is leading to a greater acceptance of mind–body medicine. EMBO Rep. 2006. Mar;7(4):358–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Johnson M. The body in the mind.: The bodily basis of meaning, imagination, and reason. (1987). University of Chicago Press. [Google Scholar]
  • 15.Coussons-Read ME. Effects of prenatal stress on pregnancy and human development: mechanisms and pathways. Obstet Med. 2013. Jun;6(2):52–7. doi: 10.1177/1753495X12473751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol. 2005;1:607–28. doi: 10.1146/annurev.clinpsy.1.102803.144141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pais M, Pai MV. Stress Among Pregnant Women: A Systematic Review. J Clin Diagn Res [Internet]. 2018. [cited 2023 Aug 15]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2018&volume=12&issue=5&page=LE01&issn=0973-709x&id=11561 [Google Scholar]
  • 18.Abera M, Hanlon C, Fedlu H, Fewtrell M, Tesfaye M, Wells JCK. Stress and resilience during pregnancy: A comparative study between pregnant and non-pregnant women in Ethiopia. Waqas A, editor. PLOS Glob Public Health. 2023. May 22;3(5):e0001416. doi: 10.1371/journal.pgph.0001416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Woods SM, Melville JL, Guo Y, Fan MY, Gavin A. Psychosocial stress during pregnancy. Am J Obstet Gynecol. 2010. Jan;202(1):61.e1–7. doi: 10.1016/j.ajog.2009.07.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vijayaselvi DrR. Risk Factors for Stress During Antenatal Period Among Pregnant Women in Tertiary Care Hospital of Southern India. J Clin Diagn Res [Internet]. 2015. [cited 2023 Aug 15]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2015&volume=9&issue=10&page=QC01&issn=0973-709x&id=6580 doi: 10.7860/JCDR/2015/13973.6580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jha S, Salve HR, Goswami K, Sagar R, Kant S. Burden of common mental disorders among pregnant women: A systematic review. Asian J Psychiatry. 2018. Aug;36:46–53. doi: 10.1016/j.ajp.2018.06.020 [DOI] [PubMed] [Google Scholar]
  • 22.Fawcett EJ, Fairbrother N, Cox ML, White IR, Fawcett JM. The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period: A Multivariate Bayesian Meta-Analysis. J Clin Psychiatry [Internet]. 2019. Jul 23 [cited 2023 Aug 15];80(4). Available from: https://www.psychiatrist.com/JCP/article/Pages/2019/v80/18r12527.aspx doi: 10.4088/JCP.18r12527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dadi AF, Miller ER, Bisetegn TA, Mwanri L. Global burden of antenatal depression and its association with adverse birth outcomes: an umbrella review. BMC Public Health. 2020. Dec;20(1):173. doi: 10.1186/s12889-020-8293-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Van den Bergh BRH, van den Heuvel MI, Lahti M, Braeken M, de Rooij SR, Entringer S, et al. Prenatal developmental origins of behavior and mental health: The influence of maternal stress in pregnancy. Vol. 117, Neuroscience and Biobehavioral Reviews. Elsevier Ltd; 2020. Oct. p. 26–64. doi: 10.1016/j.neubiorev.2017.07.003 [DOI] [PubMed] [Google Scholar]
  • 25.Ward RK, Zamorski MA. Benefits and risks of psychiatric medications during pregnancy. Am Fam Physician. 2002. Aug 15;66(4):629–36. [PubMed] [Google Scholar]
  • 26.Yu X, Liu Y, Huang Y, Zeng T. The effect of nonpharmacological interventions on the mental health of high-risk pregnant women: A systematic review. Complement Ther Med. 2022. Mar;64:102799. doi: 10.1016/j.ctim.2022.102799 [DOI] [PubMed] [Google Scholar]
  • 27.Dimidjian S, Goodman S. Nonpharmacologic Intervention and Prevention Strategies for Depression During Pregnancy and the Postpartum. Clin Obstet Gynecol. 2009. Sep;52(3):498–515. doi: 10.1097/GRF.0b013e3181b52da6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (Reprinted from Annals of Internal Medicine). Phys Ther. 2009;89(9):873–80. [PubMed] [Google Scholar]
  • 29.Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4 [DOI] [PubMed] [Google Scholar]
  • 30.Verhagen AP, De Vet HCW, De Bie RA, Kessels AGH, Boers M, Bouter LM, et al. The Delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51(12):1235–41. doi: 10.1016/s0895-4356(98)00131-0 [DOI] [PubMed] [Google Scholar]
  • 31.Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ Online. 2011;343(7829). doi: 10.1136/bmj.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beevi Z, Low WY, Hassan J. The Effectiveness of Hypnosis Intervention in Alleviating Postpartum Psychological Symptoms. Am J Clin Hypn. 2019. Apr 1;61(4):409–25. doi: 10.1080/00029157.2018.1538870 [DOI] [PubMed] [Google Scholar]
  • 33.Beevi Z, Low WY, Hassan J. The Effectiveness of Hypnosis Intervention for Labor: An Experimental Study. Am J Clin Hypn. 2017. Sep 11;60(2):172–91. doi: 10.1080/00029157.2017.1280659 [DOI] [PubMed] [Google Scholar]
  • 34.Beevi Z, Low WY, Hassan J. Impact of Hypnosis Intervention in Alleviating Psychological and Physical Symptoms During Pregnancy. Am J Clin Hypn. 2016. Apr 12;58(4):368–82. doi: 10.1080/00029157.2015.1063476 [DOI] [PubMed] [Google Scholar]
  • 35.Novelia S, Sitanggang TW, Lutfiyanti A. The Effect of Yoga Relaxation on Anxiety Levels among Pregnant Women. Nurse Media J Nurs. 2019. Mar 4;8(2):86. [Google Scholar]
  • 36.Abd Elgwad F, Mourad M, Mahmoud N. Effect of Benson’s Relaxation Therapy on Stress and Physiological Parameters among Women with Preeclampsia. Alex Sci Nurs J. 2021. Jul 1;23(1):63–74. [Google Scholar]
  • 37.Bastani F, Hidarnia A, Kazemnejad A, Vafaei M, Kashanian M. A Randomized Controlled Trial of the Effects of Applied Relaxation Training on Reducing Anxiety and Perceived Stress in Pregnant Women. J Midwifery Womens Health. 2005. Jul 8;50(4):e36–40. doi: 10.1016/j.jmwh.2004.11.008 [DOI] [PubMed] [Google Scholar]
  • 38.Chang MY, Chen CH, Huang KF. Effects of music therapy on psychological health of women during pregnancy. J Clin Nurs. 2008. Oct;17(19):2580–7. doi: 10.1111/j.1365-2702.2007.02064.x [DOI] [PubMed] [Google Scholar]
  • 39.Satyapriya M, Nagendra HR, Nagarathna R, Padmalatha V. Effect of integrated yoga on stress and heart rate variability in pregnant women. Int J Gynecol Obstet. 2009. Mar;104(3):218–22. doi: 10.1016/j.ijgo.2008.11.013 [DOI] [PubMed] [Google Scholar]
  • 40.Tragea C, Chrousos GP, Alexopoulos EC, Darviri C. A randomized controlled trial of the effects of a stress management programme during pregnancy. Complement Ther Med. 2014. Apr;22(2):203–11. doi: 10.1016/j.ctim.2014.01.006 [DOI] [PubMed] [Google Scholar]
  • 41.Chang HC, Yu CH, Chen SY, Chen CH. The effects of music listening on psychosocial stress and maternal–fetal attachment during pregnancy. Complement Ther Med. 2015. Aug;23(4):509–15. doi: 10.1016/j.ctim.2015.05.002 [DOI] [PubMed] [Google Scholar]
  • 42.Liu YH, Lee CS, Yu CH, Chen CH. Effects of music listening on stress, anxiety, and sleep quality for sleep-disturbed pregnant women. Women Health. 2016. Apr 2;56(3):296–311. doi: 10.1080/03630242.2015.1088116 [DOI] [PubMed] [Google Scholar]
  • 43.Muthukrishnan S. Effect of Mindfulness Meditation on Perceived Stress Scores and Autonomic Function Tests of Pregnant Indian Women. J Clin Diagn Res [Internet]. 2016. [cited 2023 Aug 8]; Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2016&volume=10&issue=4&page=CC05&issn=0973-709x&id=7679 doi: 10.7860/JCDR/2016/16463.7679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pan WL, Chang CW, Chen SM, Gau ML. Assessing the effectiveness of mindfulness-based programs on mental health during pregnancy and early motherhood—a randomized control trial. BMC Pregnancy Childbirth. 2019. Dec;19(1):346. doi: 10.1186/s12884-019-2503-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Guardino CM, Dunkel Schetter C, Bower JE, Lu MC, Smalley SL. Randomised controlled pilot trial of mindfulness training for stress reduction during pregnancy. Psychol Health. 2014. Mar 4;29(3):334–49. doi: 10.1080/08870446.2013.852670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yang M, Li L, Zhu H, Alexander IM, Liu S, Zhou W, et al. Music Therapy To Relieve Anxiety In Pregnant Women On Bedrest: A Randomized, Controlled Trial. MCN Am J Matern Nurs. 2009. Sep;34(5):316–23. doi: 10.1097/01.NMC.0000360425.52228.95 [DOI] [PubMed] [Google Scholar]
  • 47.Urech C, Fink NS, Hoesli I, Wilhelm FH, Bitzer J, Alder J. Effects of relaxation on psychobiological wellbeing during pregnancy: A randomized controlled trial. Psychoneuroendocrinology. 2010. Oct;35(9):1348–55. doi: 10.1016/j.psyneuen.2010.03.008 [DOI] [PubMed] [Google Scholar]
  • 48.Newham JJ, Wittkowski A, Hurley J, Aplin JD, Westwood M. EFFECTS OF ANTENATAL YOGA ON MATERNAL ANXIETY AND DEPRESSION: A RANDOMIZED CONTROLLED TRIAL: Research Article: Effects of antenatal yoga RCT on maternal anxiety. Depress Anxiety. 2014. Aug;31(8):631–40. [DOI] [PubMed] [Google Scholar]
  • 49.Davis K, Goodman SH, Leiferman J, Taylor M, Dimidjian S. A randomized controlled trial of yoga for pregnant women with symptoms of depression and anxiety. Complement Ther Clin Pract. 2015. Aug;21(3):166–72. doi: 10.1016/j.ctcp.2015.06.005 [DOI] [PubMed] [Google Scholar]
  • 50.García González J, Ventura Miranda MI, Requena Mullor M, Parron Carreño T, Alarcón Rodriguez R. Effects of prenatal music stimulation on state/trait anxiety in full-term pregnancy and its influence on childbirth: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018. Apr 18;31(8):1058–65. doi: 10.1080/14767058.2017.1306511 [DOI] [PubMed] [Google Scholar]
  • 51.Rajeswari S, SanjeevaReddy N. Efficacy of Progressive Muscle Relaxation on Pregnancy Outcome among Anxious Indian Primi Mothers. Iran J Nurs Midwifery Res. 2020;25(1):23–30. doi: 10.4103/ijnmr.IJNMR_207_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Estrella‐Juarez F, Requena‐Mullor M, Garcia‐Gonzalez J, Lopez‐Villen A, Alarcon‐Rodriguez R. Effect of Virtual Reality and Music Therapy on the Physiologic Parameters of Pregnant Women and Fetuses and on Anxiety Levels: A Randomized Controlled Trial. J Midwifery Womens Health. 2023. Jan;68(1):35–43. doi: 10.1111/jmwh.13413 [DOI] [PubMed] [Google Scholar]
  • 53.Abarghoee SN, Mardani A, Baha R, Aghdam NF, Khajeh M, Eskandari F, et al. Effects of Benson Relaxation Technique and Music Therapy on the Anxiety of Primiparous Women Prior to Cesarean Section: A Randomized Controlled Trial. Minervini G, editor. Anesthesiol Res Pract. 2022. Dec 23;2022:1–9. doi: 10.1155/2022/9986587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Simavli S, Kaygusuz I, Gumus I, Usluogulları B, Yildirim M, Kafali H. Effect of music therapy during vaginal delivery on postpartum pain relief and mental health. J Affect Disord. 2014. Mar;156:194–9. doi: 10.1016/j.jad.2013.12.027 [DOI] [PubMed] [Google Scholar]
  • 55.Simavli S, Gumus I, Kaygusuz I, Yildirim M, Usluogullari B, Kafali H. Effect of Music on Labor Pain Relief, Anxiety Level and Postpartum Analgesic Requirement: A Randomized Controlled Clinical Trial. Gynecol Obstet Invest. 2014;78(4):244–50. doi: 10.1159/000365085 [DOI] [PubMed] [Google Scholar]
  • 56.García González J, Ventura Miranda MI, Manchon García F, Pallarés Ruiz TI, Marin Gascón ML, Requena Mullor M, et al. Effects of prenatal music stimulation on fetal cardiac state, newborn anthropometric measurements and vital signs of pregnant women: A randomized controlled trial. Complement Ther Clin Pract. 2017. May;27:61–7. doi: 10.1016/j.ctcp.2017.03.004 [DOI] [PubMed] [Google Scholar]
  • 57.Chuntharapat S, Petpichetchian W, Hatthakit U. Yoga during pregnancy: Effects on maternal comfort, labor pain and birth outcomes. Complement Ther Clin Pract. 2008. May;14(2):105–15. doi: 10.1016/j.ctcp.2007.12.007 [DOI] [PubMed] [Google Scholar]
  • 58.Bastani F, Hidarnia A, Montgomery KS, Aguilar-Vafaei ME, Kazemnejad A. Does Relaxation Education in Anxious Primigravid Iranian Women Influence Adverse Pregnancy Outcomes?: A Randomized Controlled Trial. J Perinat Neonatal Nurs. 2006. Apr;20(2):138–46. doi: 10.1097/00005237-200604000-00007 [DOI] [PubMed] [Google Scholar]
  • 59.Ahmadi M, Rahimi F, Rosta F, AlaviMajd H, Valiani M. Effect of Progressive Muscle Relaxation Training on Postpartum Blues in High-risk Pregnant Women. J Holist Nurs Midwifery. 2019. Oct 30;192–9. [Google Scholar]
  • 60.Ghorbannejad S, MehdizadehTourzani Z, Kabir K, Mansoureh Yazdkhasti. The effectiveness of Jacobson’s progressive muscle relaxation technique on maternal, fetal and neonatal outcomes in women with non-severe preeclampsia: a randomized clinical trial. Heliyon. 2022. Jun;8(6):e09709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Liu YH, Chang MY, Chen CH. Effects of music therapy on labour pain and anxiety in Taiwanese first-time mothers. J Clin Nurs. 2010. Apr;19(7–8):1065–72. doi: 10.1111/j.1365-2702.2009.03028.x [DOI] [PubMed] [Google Scholar]
  • 62.Zarenejad M, Yazdkhasti M, Rahimzadeh M, Mehdizadeh Tourzani Z, Esmaelzadeh‐Saeieh S. The effect of mindfulness‐based stress reduction on maternal anxiety and self‐efficacy: A randomized controlled trial. Brain Behav [Internet]. 2020. Apr [cited 2023 Aug 11];10(4). Available from: https://onlinelibrary.wiley.com/doi/10.1002/brb3.1561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bauer I, Hartkopf J, Wikström AK, Schaal NK, Preissl H, Derntl B, et al. Acute relaxation during pregnancy leads to a reduction in maternal electrodermal activity and self-reported stress levels. BMC Pregnancy Childbirth. 2021. Dec;21(1):628. doi: 10.1186/s12884-021-04099-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Legge AW. On the Neural Mechanisms of Music Therapy in Mental Health Care: Literature Review and Clinical Implications. Music Ther Perspect. 2015;33(2):128–41. [Google Scholar]
  • 65.Dingle GA, Sharman LS, Bauer Z, Beckman E, Broughton M, Bunzli E, et al. How Do Music Activities Affect Health and Well-Being? A Scoping Review of Studies Examining Psychosocial Mechanisms. Front Psychol. 2021. Sep 8;12:713818. doi: 10.3389/fpsyg.2021.713818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Music Rebecchini L., mental health, and immunity. Brain Behav Immun—Health. 2021. Dec;18:100374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Toussaint L, Nguyen QA, Roettger C, Dixon K, Offenbächer M, Kohls N, et al. Effectiveness of Progressive Muscle Relaxation, Deep Breathing, and Guided Imagery in Promoting Psychological and Physiological States of Relaxation. Taylor-Piliae R, editor. Evid Based Complement Alternat Med. 2021. Jul 2;2021:1–8. doi: 10.1155/2021/5924040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kato K, Vogt T, Kanosue K. Brain Activity Underlying Muscle Relaxation. Front Physiol. 2019. Dec 3;10:1457. doi: 10.3389/fphys.2019.01457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Cahyati A, Herliana L, Februanti S. Progressive Muscle Relaxation (PMR) Enhances Oxygen Saturation in Patients of Coronary Heart Disease. J Phys Conf Ser. 2020. Mar 1;1477(6):062018. [Google Scholar]
  • 70.Ohmori F, Shimizu S, Kagaya A. Exercise-induced blood flow in relation to muscle relaxation period. Dyn Med. 2007. Dec;6(1):5. doi: 10.1186/1476-5918-6-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Czamanski-Cohen J, Weihs KL. The bodymind model: A platform for studying the mechanisms of change induced by art therapy. Arts Psychother. 2016. Nov;51:63–71. doi: 10.1016/j.aip.2016.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Gordon EM, Chauvin RJ, Van AN, Rajesh A, Nielsen A, Newbold DJ, et al. A somato-cognitive action network alternates with effector regions in motor cortex. Nature. 2023. May 11;617(7960):351–9. doi: 10.1038/s41586-023-05964-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Burnett-Zeigler I, Schuette S, Victorson D, Wisner KL. Mind–Body Approaches to Treating Mental Health Symptoms Among Disadvantaged Populations: A Comprehensive Review. J Altern Complement Med. 2016. Feb;22(2):115–24. doi: 10.1089/acm.2015.0038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Daviu N, Bruchas MR, Moghaddam B, Sandi C, Beyeler A. Neurobiological links between stress and anxiety. Neurobiol Stress. 2019. Nov;11:100191. doi: 10.1016/j.ynstr.2019.100191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Tafet GE, Nemeroff CB. The Links Between Stress and Depression: Psychoneuroendocrinological, Genetic, and Environmental Interactions. J Neuropsychiatry Clin Neurosci. 2016. Apr;28(2):77–88. doi: 10.1176/appi.neuropsych.15030053 [DOI] [PubMed] [Google Scholar]
  • 76.Krishnakumar D, Hamblin MR, Lakshmanan S. Meditation and Yoga can Modulate Brain Mechanisms that affect Behavior and Anxiety- A Modern Scientific Perspective. Anc Sci. 2015. Apr 1;2(1):13. doi: 10.14259/as.v2i1.171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Hölzel BK, Carmody J, Vangel M, Congleton C, Yerramsetti SM, Gard T, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res Neuroimaging. 2011. Jan;191(1):36–43. doi: 10.1016/j.pscychresns.2010.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Satyanarayana V, Lukose A, Srinivasan K. Maternal mental health in pregnancy and child behavior. Indian J Psychiatry. 2011;53(4):351. doi: 10.4103/0019-5545.91911 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Chauhan A, Potdar J. Maternal Mental Health During Pregnancy: A Critical Review. Cureus [Internet]. 2022. Oct 25 [cited 2023 Aug 26]; Available from: https://www.cureus.com/articles/108368-maternal-mental-health-during-pregnancy-a-critical-review doi: 10.7759/cureus.30656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Nillni YI, Mehralizade A, Mayer L, Milanovic S. Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: A systematic review. Clin Psychol Rev. 2018;66:136. doi: 10.1016/j.cpr.2018.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Dimidjian S, Goodman SH, Felder JN, Gallop R, Brown AP, Beck A. An open trial of mindfulness-based cognitive therapy for the prevention of perinatal depressive relapse/recurrence. Arch Womens Ment Health. 2015;18(1):85–94. doi: 10.1007/s00737-014-0468-x [DOI] [PubMed] [Google Scholar]
  • 82.Fink NS, Urech C, Cavelti M, Alder J. Relaxation during pregnancy: What are the benefits for mother, fetus, and the newborn? A systematic review of the literature. J Perinat Neonatal Nurs. 2012;26(4):296–306. doi: 10.1097/JPN.0b013e31823f565b [DOI] [PubMed] [Google Scholar]
  • 83.Richter J, Bittner A, Petrowski K, Junge-Hoffmeister J, Bergmann S, Joraschky P, et al. Effects of an early intervention on perceived stress and diurnal cortisol in pregnant women with elevated stress, anxiety, and depressive symptomatology. J Psychosom Obstet Gynecol. 2012;33(4):162–70. doi: 10.3109/0167482X.2012.729111 [DOI] [PubMed] [Google Scholar]
  • 84.Alder J, Urech C, Fink N, Bitzer J, Hoesli I. Response to induced relaxation during pregnancy: Comparison of women with high versus low levels of anxiety. J Clin Psychol Med Settings. 2011;18(1):13–21. doi: 10.1007/s10880-010-9218-z [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Fadhlun Alwy Al-beity

17 Jul 2023

PONE-D-22-31287Effect of relaxation interventions in pregnant women on maternal and neonatal outcomes: A systematic review and meta-analysisPLOS ONE

Dear Dr. Mubarak Abera 

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Kindly check for errors in the manuscript 

=========="A total of 19 studies were included in the systematic review (Error! Reference source not found.)."====================

Please submit your revised manuscript by 20 Aug 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fadhlun Alwy Al-beity, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please ensure that you refer to Figures 1-4 in your text as, if accepted, production will need this reference to link the reader to the figure.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Pregnant women at risk of preterm births are likely to have more anxiety , depression etc. Why were they excluded from the analysis?

2. Although methodology section mentions to study impact in early postnatal life . Details are missing .

Reviewer #2: Dear authors

I would like to thank you for giving me the opportunity to review the manuscript entitled “Effect of relaxation interventions in pregnant women on maternal and neonatal outcomes: A systematic review and meta-analysis”. This systematic review and meta-analysis were conducted on studies that have tested relaxation interventions to improve maternal wellbeing, and pregnancy and birth outcomes in various settings. My comments are as follows:

- This study should be included in the review: Effects of Benson Relaxation Technique and Music Therapy on the Anxiety of Primiparous Women Prior to Cesarean Section: A Randomized Controlled Trial: https://www.hindawi.com/journals/arp/2022/9986587/

- Since it has been more than a year since the search, I suggest you do the search again.

- Some citation did not reveal in the text such as P 9.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: DR PRAVEEN KUMAR

Reviewer #2: Yes: OK

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 25;19(1):e0278432. doi: 10.1371/journal.pone.0278432.r002

Author response to Decision Letter 0


1 Sep 2023

Response to Feedback

Our general response: The authors are thankful to the reviewers for taking their time to read and give us important feedback/comments on our manuscript. Now we have considered the comments and have done important edits throughout the document to improve the quality and intensity of the manuscript. Below please find point-by-point response to the issues raised. We have used track change in the main document to indicate changes.

1. Pregnant women at risk of preterm births are likely to have more anxiety, depression etc. Why were they excluded from the analysis?

Response: Thank you for this comment. Now we have included those articles in to the review.

2. Although methodology section mentions to study impact in early postnatal life. Details are missing.

Response: Now this is clarified that the aim of this study is to examine the effect of relaxation intervention on maternal wellbeing, pregnancy and birth and newborn outcomes. Our study does not assessed the impact during the early postnatal life.

3. This study should be included in the review: Effects of Benson Relaxation Technique and Music Therapy on the Anxiety of Primiparous Women Prior to Cesarean Section: A Randomized Controlled Trial: https://www.hindawi.com/journals/arp/2022/9986587/

Response: Now we have added this and other articles identified when we update the searching. Thus a total of 13 articles are added now. Consequently we have revised the manuscript consistently throughout the text.

4. Since it has been more than a year since the search, I suggest you do the search again.

Response: Now we updated this on 26 August 2023 and made the desired revisions.

5. Some citation did not reveal in the text such as P 9.

Response: Now corrected

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Daniel Ahorsu

3 Nov 2023

PONE-D-22-31287R1Effects of relaxation intervention during pregnancy on maternal mental health, and pregnancy and newborn outcomes: A systematic review and meta-analysisPLOS ONE

Dear Dr. Abera,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Daniel Ahorsu, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The author must be commended for revising the manuscript according to the reviewers' comments. However, there are still minor revision that needs to be made.

Major comments

1. As authors keep on revising their manuscript, they must make sure the revision is reflected throughout the manuscript such that there are no anomalies in numbers (e.g., the number of studies for stress, and anxiety) and reports. For instance, findings reported in the results section were different from the Figures (e.g., Fig 1—PRISMA flow charts, Figure 2 etc). Also, for some of the Figures (Figure 2, 3), if the reference is the same, authors may differentiate them with “a” and “b” so readers may appropriately identify the exact study being referred to. For instance, Guardinoa et al. 2014a and Guardinoa et al. 2014b. If it is the same study, the same style can be used but it may be indicated beneath the figure as note “that the Guardinoa et al. 2014a and –2014b are from the same study. Please authors should make sure they rectify all these inconsistencies.

• Nine trials on maternal perceived stress during pregnancy using PSS (30–38), 12 trials on anxiety during pregnancy using the State-Trait Anxiety Inventory (S-TAI) (30,31,33,35,38–45), 7 trials on antenatal and postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS) (31,37,41,42,44,46,47), and 6 trials reported birth weight in grams or kilograms (44,48–52)

2. The reviewer commented on a missing reference for a study that was added

In all, I suggest that the authors thoroughly go through and revise the manuscript to make sure there are no inconsistencies or missing data/information in the manuscript. Especially, they should go through the results section once more and update the discussion section appropriately.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for making necessary changes . This study will help in management of mothers with psychological stress.

Reviewer #2: Dear authors

Thank you for addressing my comments.

Some studies that were added newly were not included in the reference list. For instance, Abarghoee SN, et al. 2022

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: DR PRAVEEN KUMAR

Reviewer #2: Yes: OK

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 25;19(1):e0278432. doi: 10.1371/journal.pone.0278432.r004

Author response to Decision Letter 1


15 Nov 2023

Our general response: The authors are thankful to the reviewers for taking their time to read and give us important feedback/comments on our manuscript. Now we have considered the comments and have done important edits throughout the document to improve the quality and intensity of the manuscript. Below please find point-by-point response to the issues raised. We have used track change in the main document to indicate changes.

1. As authors keep on revising their manuscript, they must make sure the revision is reflected throughout the manuscript such that there are no anomalies in numbers (e.g., the number of studies for stress, and anxiety) and reports. For instance, findings reported in the results section were different from the Figures (e.g., Fig 1—PRISMA flow charts, Figure 2 etc). Also, for some of the Figures (Figure 2, 3), if the reference is the same, authors may differentiate them with “a” and “b” so readers may appropriately identify the exact study being referred to. For instance, Guardinoa et al. 2014a and Guardinoa et al. 2014b. If it is the same study, the same style can be used but it may be indicated beneath the figure as note “that the Guardinoa et al. 2014a and –2014b are from the same study. Please authors should make sure they rectify all these inconsistencies.

Response: These now are corrected on the search flow diagram (fig 1), and all other figures (fig 2-5) by avoiding inconsistencies in the number and type of studies. Findings from similar studies are noted as ‘a’ and ‘b” as recommended by reviewer.

2. Nine trials on maternal perceived stress during pregnancy using PSS (30–38), 12 trials on anxiety during pregnancy using the State-Trait Anxiety Inventory (S-TAI) (30,31,33,35,38–45), 7 trials on antenatal and postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS) (31,37,41,42,44,46,47), and 6 trials reported birth weight in grams or kilograms (44,48–52)?

Response: this statement is now also revised and clarified in the main document as “Among the 27 RCT studies, 9 trials were on maternal perceived stress during pregnancy using PSS (35–43), 13 trials on anxiety during pregnancy using the State-Trait Anxiety Inventory (S-TAI) (35,36,38,40,43–51), 7 trials on antenatal and postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS) (30,36,42,46,47,49,52), and 8 trials were on birth weight and reported weight in grams or kilograms (31,49,53–58).

3. The reviewer commented on a missing reference for a study that was added. In all, I suggest that the authors thoroughly go through and revise the manuscript to make sure there are no inconsistencies or missing data/information in the manuscript. Especially, they should go through the results section once more and update the discussion section appropriately.

Response: Now missing references are included (4 studies). Moreover the result and discussion section has been thoroughly edited.

4. Some studies that were added newly were not included in the reference list. For instance, Abarghoee SN, et al. 2022

Response: now this and other missed studies are included.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Daniel Ahorsu

20 Nov 2023

PONE-D-22-31287R2Effects of relaxation interventions during pregnancy on maternal mental health, and pregnancy and newborn outcomes: A systematic review and meta-analysisPLOS ONE

Dear Dr. Abera,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 04 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Daniel Ahorsu, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

The authors have appropriately revised the manuscript but more needs to be done as mentioned in my previous comments.

Going through the data once more, I realized that the data were wrongly reported in Figure 2 (stress). Please recheck the mean difference for PMR/BR. It is not -13.1 but rather -8.1, (95%CI -17.80, 1.6) and this mean difference is not significant. Anytime a reader or researcher consuming your manuscript sees such an anomaly, it casts doubt on whether the whole manuscript can be trusted. This is a medical/health-related manuscript which will significantly impact how we treat people so data should be thoroughly checked before submission. Although reviewers are to help check these, the absolute responsibility rests with authors and not reviewers and editors.

The same issue, especially with PMR/BR can be found in anxiety figure 3. Again, although MD was -8.61 the 95%CI contains “0” which means it is not significant.

I am very sure I can get so many examples If I spend hours going through the manuscript again. So, I will entreat the authors to go through it once more or better still let another neutral person edit it before re-submission.

I also noticed that there were “Trails” instead of “trials” in the results (3 times).

Importantly, please prepare a response letter detailing point-by-point where the revision was made and with page numbers so I can quickly cross-check.

All the best.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 25;19(1):e0278432. doi: 10.1371/journal.pone.0278432.r006

Author response to Decision Letter 2


24 Nov 2023

Response to review feedback

Our general response: we are really very thankful to the editor for giving us this opportunity to correct and make thorough edits to the manuscript. Accordingly all the authors including neutral reader have gone through the manuscript and made a detail read and added the necessary edits and corrections. Moreover below we have indicated for specific corrections we have made.

1. Going through the data once more, I realized that the data were wrongly reported in Figure 2 (stress). Please recheck the mean difference for PMR/BR. It is not -13.1 but rather -8.1, (95%CI -17.80, 1.6) and this mean difference is not significant.

Response: Again we thank you for this feedback. The confusion happen when we report finding from individual PMR/BR trial without reporting the finding from the overall subgroup analysis in the text. So now we have clarified and corrected this as follow on page 10. “In a subgroup analysis although PMR/BR as a group showed no significant association (mean difference -8.1, 95% CI: -17.8, 1.6), an individual PMR/BR trial (mean difference: -13.1; 95% CI:-15.3, -11.0) and meditation therapy (mean difference: -13.1; 95% CI:-14.0, -12.2) showed the highest effect size while music therapy as a group showed the lowest effect size (mean difference = -0.8; 95% CI:-1.5, -0.1).”

2. The same issue, especially with PMR/BR can be found in anxiety figure 3. Again, although MD was -8.61 the 95%CI contains “0” which means it is not significant.

Response: We have also corrected and clarified this as follows on page 11. “In the subgroup analysis although PMR/BR trials as a group showed no association (mean difference: -8.6; 95% CI: -22.6, 5.4), individual PMR/BR trials showed the highest effect size of -15.8 (mean difference: -15.8; 95% CI: -18.3, -13.3) and lowest effect size of -1.5 (mean difference: -1.5; 95% CI: -2.9, -0.1) in reducing symptoms of anxiety.”

3. Cortical spelling errors on Trial vs Trails:

Response: We are very sorry for this and we have corrected them on three different sites in the main document page 9, 11 & 12.

4. I will entreat the authors to go through it once more or better still let another neutral person edit it before re-submission.

Response: Thank you for this supportive feedback. Now the paper is thoroughly read and edited by all the authors and neutral reader and made important edits as can be seen in the track changed version of the main document.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 3

Daniel Ahorsu

30 Nov 2023

PONE-D-22-31287R3Effects of relaxation interventions during pregnancy on maternal mental health, and pregnancy and newborn outcomes: A systematic review and meta-analysisPLOS ONE

Dear Dr. Abera,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Daniel Ahorsu, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

The authors have revised the manuscript which has greatly improved the manuscript. However, I noticed that although the results have changed, it did not reflect in the discussion. Hence, I have provided a few comments to help the authors reflect on the results and discussion sections.

1. Authors should be consistent in how they report the sub-group analysis. A significant MD is what is important first and then the size of the MD and not the other way round. That is, if the MD is super high but it is not significant means nothing research-wise although noteworthy. Hence, I may suggest that authors report those MDs that are significant and then the MD sizes of those significant MDs. Then other super high non-significant MD may be mentioned as noteworthy cases.

2. Authors may choose to mention that the MD of for instance PMR/BR is the highest but the point is that it is not significant and so, research-wise, it does not matter as it can be equated to the other non-significant sub-group analysis. The main point is to clearly discuss why you had these results in the discussion section. In other words, clearly discuss the reasons behind the high MD but non-significant results. This applies to stress and anxiety.

3. Again, if authors will be mentioning sub-group results, then they should be ready to discuss those results. The discussion should also mention the limitations including the effect of single studies for some sub-groups. This is to help consumers understand the results clearly and know the pros and cons of using your findings. As mentioned previously, this manuscript will go a long way to influence clinical decisions and so sentences should be constructed with great caution.

4. Limitations: single studies in some subgroups analysis and their effect

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 25;19(1):e0278432. doi: 10.1371/journal.pone.0278432.r008

Author response to Decision Letter 3


15 Dec 2023

Our response: Again we are very thankful to the editor for giving us these review feedback. Accordingly we have revised and made a careful necessary corrections. Below we have indicated for specific corrections we have made.

1. Authors should be consistent in how they report the sub-group analysis. A significant MD is what is important first and then the size of the MD and not the other way round. That is, if the MD is super high but it is not significant means nothing research-wise although noteworthy. Hence, I may suggest that authors report those MDs that are significant and then the MD sizes of those significant MDs. Then other super high non-significant MD may be mentioned as noteworthy cases.

Response: Thank you for this comment. Now we have corrected this accordingly and followed a consistent reporting for subgroup analysis in the text. Corrections are made on page 10-12.

2. Authors may choose to mention that the MD of for instance PMR/BR is the highest but the point is that it is not significant and so, research-wise, it does not matter as it can be equated to the other non-significant sub-group analysis. The main point is to clearly discuss why you had these results in the discussion section. In other words, clearly discuss the reasons behind the high MD but non-significant results. This applies to stress and anxiety.

Response: Yes we agree and accept this critical comment. Now we have chosen to report in the text only those that are statistically significant and discussed them accordingly. Corrections are made on page 10-12 and also page 14-16.

3. Again, if authors will be mentioning sub-group results, then they should be ready to discuss those results. The discussion should also mention the limitations including the effect of single studies for some sub-groups. This is to help consumers understand the results clearly and know the pros and cons of using your findings. As mentioned previously, this manuscript will go a long way to influence clinical decisions and so sentences should be constructed with great caution.

Response: This is also well addressed in the discussion and limitation sections. Corrections are made on page 14-16.

4. Limitations: single studies in some subgroups analysis and their effect

Response: This is now added in the limitation section as “Because of lack of literature, some of the subgroup analysis involved only single study”. Corrections are made on page 17.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 4

Daniel Ahorsu

26 Dec 2023

Effects of relaxation interventions during pregnancy on maternal mental health, and pregnancy and newborn outcomes: A systematic review and meta-analysis

PONE-D-22-31287R4

Dear Dr. Abera,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Daniel Ahorsu, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Daniel Ahorsu

17 Jan 2024

PONE-D-22-31287R4

PLOS ONE

Dear Dr. Abera,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Daniel Ahorsu

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Quality assessment report for risk of bias for included studies in the review based on the Cochrane Collaboration’s risk of bias assessment tool.

    (DOCX)

    S2 Table. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES